Sionna Therapeutics, Inc.
SION · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $1,103 | $1,103 | $1,103 |
| - Cash | $38 | $39 | $55 |
| + Debt | $10 | $10 | $0 |
| Enterprise Value | $1,075 | $1,075 | $1,048 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | -$1 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$70 | -$50 | -$41 |
| % Margin | – | – | – |
| Net Income | -$62 | -$47 | -$40 |
| % Margin | – | – | – |
| EPS Diluted | -1.4 | -1.071 | -0.912 |
| % Growth | -30.7% | -17.4% | – |
| Operating Cash Flow | -$53 | -$44 | -$36 |
| Capital Expenditures | -$0 | -$1 | -$2 |
| Free Cash Flow | -$53 | -$45 | -$38 |